期刊文献+

血清补体3与代谢综合征及胰岛素抵抗关系研究 被引量:2

Associations of the serum C3 level with metabolic syndrome and insulin resistance
原文传递
导出
摘要 目的探讨血清补体3(C3)与代谢综合征(MS)及其组分,以及胰岛素抵抗(IR)的关系。方法96例MS患者和141例非MS患者用免疫比浊法检测血清C3,同时检测:BMI、血糖、血压、血脂。结果MS患者血清C3水平明显高于非MS患者,且C3水平随MS组分的增加而升高(P<0.01)。相关分析显示血清C3浓度与BMI、SBP、FPG、TC、TG、HOMA-IR呈正相关。结论血清C3水平与MS组分相关,与IR有关。 Objective To determine the association of serum C3 with metabolic syndrome(MS) and its components and insulin resistance. Methods 96 subjects with MS and 141 subjects without MS were included in this sdudy. Serum C3 were measured by immunoturbidimetry. BMI, blood pressure, blood glucose and fasting lipids were measured. Results The level of serum C3 was significantly higher in subjects with MS components than without the components ( 1.56±0.43 vs 0. 97±0.20 P〈 0. 01 ). Increased number of the MS components resulted in higher serum levels of C3 (P〈0.01). Correlation analysis indicated that serum C3 level was asscociated positively with BMI, SBP, FPG, TC, TG, HOMA-IR. Conclusions Serum C3 level is closely related to the components of metabolic syndrome and insulin resistance.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2009年第5期350-352,共3页 Chinese Journal of Diabetes
关键词 血清C3 代谢综合征 胰岛素抵抗 Complement 3 Metabolic syndrome Insulin resistance
  • 相关文献

参考文献2

二级参考文献17

  • 1Hansen TK,Thiel S,Knudsen ST,et al.Elevated levels of mannan-binding lectin in patients with type 1 diabetes[J].J Clin Endocrinol Metab,2003 ;88:4857-61.
  • 2Figueredo 4,Ibarra JL,Bagazgoitia J,et al.Plasma C3 levels and ischemic heart disease in type Ⅱ diabetes[J].Diabetes Care,1993; 16:445-9.
  • 3Uesugi N,Sakata N,Nangaku M,et al.Possible mechanism for medial smooth muscle cell injury in diabetic nephropathy:glycoxidation-mediated local complement activation[J].Am J Kidney Dis,2004 ;44:224-38.
  • 4Zhang J,G erhardinger C,Lorenzi M.Early complement activation and decreased levels of glycosyl phosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy[J].Diabetes,2002 ;51:3499-504.
  • 5Weyer C,Tataranni PA,Prathy RE.Insulin action and insulinemia are closely related to the fasting complement C3,but not acylation stimulating protein concentration[J].Diabetes Care,2000 ;23:779-85.
  • 6Széplaki G,Prohászka Z,Duba J,et al.Association of high serum concentration of the third component of complement(C3) with preexisting severe coronary artery disease and new vascular event in women[J].Atherosclerosis,2004; 177:383-9.
  • 7Muscari A,Massarelli G,Bastagli L,et al.Relationship of serum C3 to fasting insulin,risk factors and previous ischaemic events in middle-aged men[J].Eur Heart J,2000;21:1081-90.
  • 8Muscari A,Bozzoli C,Gerratana C,et al.Association of serum IgA and C4 with severe atherosclerosis[J].Atherosclerosis,1988 ;74:179-86.
  • 9Halkes C J,van Dijk H,de Jaegeve PP,et al.Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease effects of expanded-dose simvastatin[J].Arterioscler Thromb Vasc Biol,2001 ;21:1526-30.
  • 10Koistinen HA,Vidal H,Karonen SL,et al.Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men[J].Arterioscler Thromb Vasc Biol,2001 ;21:1034-9.

共引文献3093

同被引文献19

  • 1宋克群,于慧玲,冯长顺,戴华,李幼阳,蔡兰平,唐丽君,贾小清,任素琴,薛长勇.老年男性代谢综合征患者体脂分布[J].中国老年学杂志,2014,34(8):2282-2283. 被引量:4
  • 2中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3089
  • 3刘红梅,李启富,张素华,青华,高虹.血清超敏C反应蛋白与代谢综合征及其组分的关系[J].中华糖尿病杂志(1006-6187),2005,13(5):348-350. 被引量:17
  • 4van Oostrom AJ, Alipour A, Plokker TW, et al. The metabolic syndrome in relation to complement component 3 and post prandial lipemia in patients from an outpatient lipid clinic and healthy volunteers. A therosclerosis, 2007, 190:167-173.
  • 5International Diabetes Federation. The IDF consensus world-wide definition of the metabolicsyndrome[EB/OL]. 2009-12-05 [-2010-10-101. http://www.idf. org/webdata/docs/IDF_Metasyndrome_definition, pdf.
  • 6Lim S, Lee HK, Kimm KC, et al. C-reactive protein level as an independent risk factor of metabolic syndrome in the Korean population. CRP as risk factor of metabolic syndrome. Diabetes Res Clin Pract, 2005, 70:126-133.
  • 7Hemdndez-Mijares A, Jarabo-Bueno M, L6pez-Ruiz A, et al. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors. Int J Obes, 2007, 31:927-932.
  • 8Meijssen S, van Dijk H, Verseyden C, et al. Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol, 2002, 22:811-816.
  • 9Mantov S, Raev D. Additive effects of diabetes and systemic hypertension on the immune mechanisms of atherosclerosis. Int J Cardiol, 1996, 56:145-148.
  • 10Herndndez-Mijares A, Jarabo-Bueno MM, Lopez-Ruiz A, et al. Levels of C3 in patients with severe,morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors. Int J Obesity, 2007, 31:927-932.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部